Tape-Mechanics Bounce Offers No All-Clear: Monday delivered a mechanical bounce rather than a fundamental all-clear. The S&P 500 added 22 points and the Nasdaq jumped 0.86%, led by a partial rebound in the semiconductor cohort. However, conviction underneath the bounce was exceptionally thin. Volume profiles pointed to systematic short covering and volatility-target rebalancing rather than true dip-buying. Meanwhile, crude experienced a violent whipsaw, spiking to $97.15 on weekend geopolitical strikes before fading back to $94 on de-escalation headlines.
The Fed Setup Just Got Materially Harder: Following Friday’s blowout May jobs report (172k vs 80k consensus) and upward revisions to prior months, the bar for a dovish Fed surprise has effectively collapsed. The CME FedWatch tool has seen a remarkable shift, now pricing in a 58% implied probability of at least one rate hike by December. The upcoming June FOMC meeting will be Chair Kevin Warsh’s first, and the market is bracing for a higher-for-longer reality.
Inflation Data Serves as the Ultimate Gate: With the labor market printing hot, Wednesday’s May CPI release serves as the definitive gate for the FOMC. A hot inflation print on top of the strong jobs number would cement rate hike pricing and force a severe re-rating of long-duration tech. An in-line or softer print remains the only realistic path back to a benign policy outlook.
The AI Capex Thesis Faces Severe Stress-Testing: Friday’s massive semiconductor rout was initially triggered by Broadcom’s guidance disappointment and subsequently accelerated by the hot payrolls print, which carries higher-borrowing-cost implications for debt-funded data center buildouts. Monday’s light bounce did not invalidate these structural concerns; it merely tested if the dip would be bought. Going forward, the market will heavily penalize any execution weakness in the AI complex.
💰 The Income Generators (High Probability, Cash Flow)
IBKR: Bullish Put Spread targeting a powerful volume-driven technical breakout pushing toward a new major upside target.
🚀 The Growth Seekers (Higher Risk, Max Reward)
DXCM: Bullish Call Spread aggressively adding to an existing winning position following a confirmed technical breakout.
🛡️ The Portfolio Protectors (Hedges & Bearish Bets)
(No trades in this category today)
1. IBKR ($87.35): The Breakout Momentum
We’re betting on: If Interactive Brokers sustains its strong relative strength and volume momentum following its major breakout, the stock will push aggressively toward our $100 objective while remaining above our short put strike.
The Trade: Sell to Open the IBKR Jul 24, 2026 85/80 Put Vertical @ $2.22 Credit.
🟢 BUY TO OPEN Jul 24, 2026 80 Put @ $2.28
🔴 SELL TO OPEN Jul 24, 2026 85 Put @ $4.50
Trade Metrics: POP: 59.01% | Collect $222.00 per contract vs. a Max Risk of $278.00 (1.25:1).
The Setup: Interactive Brokers has triggered a high-conviction breakout above its heavy $80 resistance level, fueled by accelerating volume and exceptional relative strength. The financial sector is catching a robust bid as capital rotates out of rate-sensitive growth into liquid capital markets leaders. With the stock crossing above major moving averages, the technical path is clear for a continuation run toward $100. This short put spread provides a high-probability income structure to capitalize on the new support floor.
Management:
⚠️ Warning: Earnings are scheduled for July 14, potentially requiring active monitoring around the event.
Stop Loss: Buy back the spread at $4.44 (100% of credit received).
Take Profit: Buy back the spread at $1.11 (50% of max gain).
2. DXCM ($76.62): Compounding the Medical Device Winner
We’re betting on: If Dexcom leverages its confirmed relative strength to extend its fresh technical breakout, this long vertical spread will expand rapidly toward our higher upside targets.
The Trade: Buy to Open the DXCM Jul 17, 2026 75/85 Call Vertical @ $3.72 Debit.
🟢 BUY TO OPEN Jul 17, 2026 75 Call @ $5.30
🔴 SELL TO OPEN Jul 17, 2026 85 Call @ $1.58
Trade Metrics: POP: 39.33% | Pay $372.00 per contract vs. a Max Reward of $628.00 (1.7:1).
The Setup: We initially established a bullish position in Dexcom on June 1st anticipating a breakout above $75. That breakout has now fully materialized, backed by confirmed relative strength and expanding volume as the broader market rotates into defensive healthcare growth. This presents a textbook opportunity to add to a winning position and swing for a potential home run as we target the $93.76 level on the upside.
Management:
Stop Loss: Sell the spread at $1.86 (50% loss on premium).
Take Profit: Sell the spread at $6.51 (75% gain on premium).
Share this on